Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleArticles on Covid-19

Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19

ALICE G. VASSILIOU, IOANNA DIMOPOULOU, EDISON JAHAJ, CHRYSI KESKINIDOU, ZAFEIRIA MASTORA, STYLIANOS E. ORFANOS and ANASTASIA KOTANIDOU
In Vivo March 2021, 35 (2) 1295-1298; DOI: https://doi.org/10.21873/invivo.12381
ALICE G. VASSILIOU
1First Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IOANNA DIMOPOULOU
1First Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EDISON JAHAJ
1First Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRYSI KESKINIDOU
1First Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ZAFEIRIA MASTORA
1First Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STYLIANOS E. ORFANOS
1First Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece;
2Second Department of Critical Care, School of Medicine, National and Kapodistrian University of Athens, Attikon Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANASTASIA KOTANIDOU
1First Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: akotanid@med.uoa.gr
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 35 no. 2 1295-1298
DOI 
https://doi.org/10.21873/invivo.12381
PubMed 
33622933

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received January 8, 2021
  • Revision received January 20, 2021
  • Accepted January 22, 2021
  • Published online February 23, 2021.

Copyright & Usage 
Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. ALICE G. VASSILIOU1,
  2. IOANNA DIMOPOULOU1,
  3. EDISON JAHAJ1,
  4. CHRYSI KESKINIDOU1,
  5. ZAFEIRIA MASTORA1,
  6. STYLIANOS E. ORFANOS1,2 and
  7. ANASTASIA KOTANIDOU1⇑
  1. 1First Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece;
  2. 2Second Department of Critical Care, School of Medicine, National and Kapodistrian University of Athens, Attikon Hospital, Athens, Greece
  1. Correspondence to: Prof. Anastasia Kotanidou, MD, 1st Department of Critical Care Medicine and Pulmonary Services School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, 45-47 Ipsilantou St, 106 76, Athens, Greece. Tel: +30 2107243320, Fax: +30 2107216503, e-mail: akotanid{at}med.uoa.gr
View Full Text
PreviousNext
Back to top

In this issue

In Vivo: 35 (2)
In Vivo
Vol. 35, Issue 2
March-April 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
9 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19
ALICE G. VASSILIOU, IOANNA DIMOPOULOU, EDISON JAHAJ, CHRYSI KESKINIDOU, ZAFEIRIA MASTORA, STYLIANOS E. ORFANOS, ANASTASIA KOTANIDOU
In Vivo Mar 2021, 35 (2) 1295-1298; DOI: 10.21873/invivo.12381

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19
ALICE G. VASSILIOU, IOANNA DIMOPOULOU, EDISON JAHAJ, CHRYSI KESKINIDOU, ZAFEIRIA MASTORA, STYLIANOS E. ORFANOS, ANASTASIA KOTANIDOU
In Vivo Mar 2021, 35 (2) 1295-1298; DOI: 10.21873/invivo.12381
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results and Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The Impact of COVID-19 Infection on the Postoperative Outcomes in Pancreatic Cancer Patients
  • The Experience of Greece as a Model to Contain COVID-19 Infection Spread
Show more Articles on Covid-19

Similar Articles

Keywords

  • COVID-19
  • cytokine storm
  • critically-ill
  • ICU
In Vivo

© 2021 In Vivo

Powered by HighWire